Jonathan Jan Ilve Thorsen

Jonathan Jan Ilve Thorsen


  1. 2024
  2. Published

    Escherichia coli CRISPR arrays from early life fecal samples preferentially target prophages

    Dion, M. B., Shah, S. A., Deng, Ling, Thorsen, Jonathan Jan Ilve, Stokholm, Jakob, Krogfelt, K. A., Schjørring, S., Horvath, P., Allard, A., Nielsen, Dennis Sandris, Petit, M. A. & Moineau, S., 2024, In: The ISME Journal. 18, 1, 9 p., wrae005.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: A Danish nationwide cohort study

    Ring, H. C., Thorsen, Jonathan Jan Ilve, Kirby, B., Ingram, J. R., Rosenø, N. A. L., Holgersen, N., Nielsen, V. W., Nikolai Thein Aagaard, D., Maul, J., Wu, J. J., Thyssen, Jacob Pontoppidan, Egeberg, Alexander & Thomsen, Simon Francis, 2024, In: British Journal of Dermatology, Supplement. 190, 5, p. 769–771

    Research output: Contribution to journalComment/debateResearchpeer-review

ID: 215672837